The Federal Trade Commission (FTC) recently reminded the three companies which were selling tinctures, oils, gummies, capsules, and creams containing cannabidiol (CBD) that promoting false statements about CBD supplement benefits may be against the law.
The bureau sent letters to three of the unnamed companies, warning them about making false labeled CBD supplement claims without having any scientific proof to back it up.
One of the companies websites claimed that its CBD products were clinically proven to treat diseases like cancer, fibromyalgia, Alzheimer’s disease, addiction, colitis, and MS. According to the federal trade commission, the company strengthened the claims with citations of thousands of hours of research by Harvard researchers.
False Labeled CBD Supplement Claims
Another company allegedly claimed that CBD is helpful in the treatment of autism, post-traumatic stress disorder, anorexia, schizophrenia, Lou Gehrig’s disease, epilepsy, Crohn’s disease, Parkinson’s disease, fibromyalgia, AIDS, cancer and many more. This manufacturer allegedly commends CBD supplement as a miracle treatment that could help with pain caused by arthritis andcancer.
another website allegedly said that CBD gummies could treat most major degenerative diseases, such as heart disease, arthritis, cancer, fibromyalgia, asthma and a wide variety of autoimmune diseases. The company allegedly made more claims that it is CBD cream that could treat arthritis pain, while its CBD oil that can help in the treatment of depression, epilepsy, PTSD, heart disease, arthritis, asthma, and fibromyalgia.
The letters notify the companies, which the Federal trade commission is not recognizing it publicly, that it is unlawful to promote a product that can treat, cure or prevent human disorders without adequateand reliable scientific proofs to back up such claims, the FTC said in a press release.
The companies that received a warning letter from the FTC has fifteen days to respond. The reply must comprise any measures that have been taken to abideby FTC rules and regulations.
CBD (cannabidiol) is a very useful organic remedy with lots of anecdotal confirmations to keep up its benefits. However, claims regarding CBD supplement benefits are not scientifically tested and the false labeled CBD products have not been accepted by the FDA as medical treatments.
The promotions of CBD supplements, gummies, oil, liquid, balm, and many more can be additionally obscured by the fact of what can be found in the products. Although some reputable dealers provide third party testing outcomes to confirm the quality and vigor of their products, customers have claimed that few CBD products do not carry the amount of the active ingredient which is being promoted.
Some CBD Supplement highlights:
- One of the letter specifically mentions a CBD isolate product (blue CBD crystals isolate 1500 mg). Some have advanced arguments that a CBD isolates product is different from the FDA-approved CBD drug, Epidiolex. But these recent actions indicate that the FDA does not agree that a CBD isolate product can be permitted to introduce into the interstate business.
- FDA declares that the products are mis-branded, unaccepted by new human or animal drugs.
- FDA says the products are promoted as dietary supplements but do not they meet the meaning of a dietary supplement.
- FDA quotes them as misleading, as they imply that CBD fights cancer and has an anti-tumor effect.
- FDA states that the use of a nutrition facts panel on a CBD oil is unsuitable because the oil is food into which a drug has been added.the Federal Food, Drug, and Cosmetic Act prohibit the addition into interstate trading of any food to which CBD has been added.
- FTC asserts that it is illegal under the FTC Act to promote products that can treat, prevent or cure human diseases unless a company produces scientific proofs which include human clinical studies, that confirm the claims at the time they are made.
- FTC says that making or overemphasized claims, directly or indirectly, by using the product name, website name, meta tags or any other means without scientific proofs sufficient to verify the claims violates the FTC Act.
- FTC cites specific actions it will take with respect to the products subject of the letter:
- A federal district court injunction. and/or
- An administrative cease and abstain order, which might make the company to repay to the consumers against the product sold.
False Labeled CBD Products Class Action Lawsuit Investigation
If you bought a CBD supplement, it may not have contained or might have contained very few active elements that you were made to believe in the promotions, and you may be eligible to join this False Labeled CBD products class action lawsuit investigation.
Shamis & Gentile, P.A. is a firm that can help you in your class action lawsuit investigations.